INTERNATIONAL PATENT: INSILICO MEDICINE IP LIMITED FILES APPLICATION FOR "NLRP3 INFLAMMASOME INHIBITORS AND USES THEREOF"

GENEVA, Nov. 17 -- INSILICO MEDICINE IP LIMITED (26th Floor, Three Exchange Square, 8 Connaught Place CentralHong Kong) filed a patent application (PCT/CN2025/093470) for "NLRP3 INFLAMMASOME INHIBITORS AND USES THEREOF" on May 08, 2025. With publication no. WO/2025/232839, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Jianping (Suite 901, Tower C, Changtai Plaza, 2889 Jinke RoadPudong New Area, Shanghai 201203), QIN, Luoheng (Suite 901, Tower C, Changtai Plaza, 2889 Jinke RoadPudong New Area, Shanghai 201203), DING,...